Considering the unique therapeutic potential of mesenchymal stem cells (MSCs), including
their immunosuppressive and immunomodulatory properties as well as their ability to …

Diabetic cardiomyopathy (DCM) mainly refers to myocardial metabolic dysfunction caused
by high glucose, and hyperglycemia is an independent risk factor for cardiac function in the …

Diabetes is a major risk factor for cardiovascular diseases, including diabetic
cardiomyopathy, atherosclerosis, myocardial infarction, and heart failure. As cardiovascular …

Introduction Cell therapy with mesenchymal stem cells (MSCs) and biomaterials holds great
potential for the treatment of diabetic ulceration; however, the underlying mechanism as well …

Pathologies of the vasculature including the microvasculature are often complex in nature,
leading to loss of physiological homeostatic regulation of patency and adequate perfusion to …

Homing of mesenchymal stem cells (MSCs) to the defect site is indispensable for bone
repair. Local endothelial cells (ECs) can recruit MSCs; however, the mechanism remains …

Stem cell therapy is a promising alternative approach to heart diseases. The most prevalent
source of multipotent stem cells, usually called somatic or adult stem cells (mesenchymal …

The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the
resulting cardiac complications are the leading cause of death. Among these complications …

Stem cell-based therapy raises hopes for a better approach to promoting tissue repair and
functional recovery. However, transplanted stem cells show a high death percentage …

Stem cell therapies have shown promising therapeutic effects in restoring damaged tissue
and promoting functional repair in a wide range of human diseases. Generations of insulin …